{"id":"carbetocin-infusion","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Flushing"},{"rate":null,"effect":"Tachycardia"}]},"_chembl":{"chemblId":"CHEMBL3301668","moleculeType":"Protein","molecularWeight":"988.18"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Carbetocin mimics the natural hormone oxytocin by activating oxytocin receptors on uterine smooth muscle, triggering sustained contractions that help control postpartum hemorrhage and facilitate milk ejection during lactation. It has a longer duration of action and more selective receptor binding compared to natural oxytocin, making it effective at lower doses.","oneSentence":"Carbetocin is a synthetic oxytocin analogue that binds to oxytocin receptors to stimulate uterine contractions and promote milk letdown.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:16:58.314Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention and treatment of postpartum hemorrhage"},{"name":"Promotion of milk letdown in lactation"}]},"trialDetails":[{"nctId":"NCT06692621","phase":"","title":"Effects of Carbetocin and Oxytocin Used in Cesarean Sections on Postoperative Pain","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2024-10-04","conditions":"PREG1","enrollment":120},{"nctId":"NCT06333340","phase":"NA","title":"Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery","status":"RECRUITING","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2025-01-14","conditions":"Post Partum Hemorrhage","enrollment":160},{"nctId":"NCT05924321","phase":"PHASE1","title":"A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy Subjects","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2023-05-25","conditions":"Postpartum Hemorrhage","enrollment":40},{"nctId":"NCT06060327","phase":"NA","title":"Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-10-15","conditions":"Postpartum Hemorrhage, Blood Loss, Postoperative, Cesarean Section Complications","enrollment":440},{"nctId":"NCT05664659","phase":"PHASE4","title":"Efficacy of Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Blood Loss During Cesarean Section","status":"COMPLETED","sponsor":"Ain Shams Maternity Hospital","startDate":"2022-12-20","conditions":"Blood Loss, Surgical, Intrapartum Hemorrhage","enrollment":90},{"nctId":"NCT05110482","phase":"PHASE4","title":"Carbetocin Versus Syntocinon for Prevention of Postpartum Hemorrhage in Cardiac Patients Undergoing Caesarean Section","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2021-11-30","conditions":"Adverse Effect of Oxytocic Drugs","enrollment":38},{"nctId":"NCT03651882","phase":"PHASE4","title":"Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2018-08-07","conditions":"Postpartum Hemorrhage","enrollment":550},{"nctId":"NCT05806307","phase":"PHASE4","title":"Methods Decreasing Bleeding in Open Myomectomy","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-03-15","conditions":"Misoprostol Allergy, Oxytocin Allergy, Tranexamic Acid Allergy","enrollment":105},{"nctId":"NCT05758012","phase":"","title":"Carbetocin Compared To Oxytocin During Cesarean Delivery","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-05-01","conditions":"Cesarean Delivery","enrollment":260},{"nctId":"NCT04902729","phase":"NA","title":"Oxytocin vs Carbetocin at Cesarean Delivery in Women With Morbid Obesity","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2021-07-20","conditions":"Post Partum Hemorrhage","enrollment":48},{"nctId":"NCT05467462","phase":"NA","title":"Efficacy of Four Different Treatment Regimes on Postpartum Hemorrhage","status":"COMPLETED","sponsor":"Bezmialem Vakif University","startDate":"2022-08-01","conditions":"Postpartum Hemorrhage","enrollment":300},{"nctId":"NCT04201665","phase":"NA","title":"EMG for Uterotonic Efficiency Estimation","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2020-09-13","conditions":"Postpartum Hemorrhage","enrollment":60},{"nctId":"NCT05083910","phase":"NA","title":"Randomization of Oxytocin, Oxytocin+Intrauterine Misoprostol and Carbetocin During C-section","status":"COMPLETED","sponsor":"Bezmialem Vakif University","startDate":"2021-07-01","conditions":"Postpartum Hemorrhage","enrollment":156},{"nctId":"NCT03404544","phase":"PHASE4","title":"Impact of Carbetocin Administration on Heart Rate When Given as an Infusion Versus as a Bolus.","status":"COMPLETED","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2018-06-11","conditions":"Cesarean Section Complications, Hemodynamic Instability","enrollment":70},{"nctId":"NCT03870503","phase":"NA","title":"Carbetocin Versus Oxytocin Plus Sublingual Misoprostol in the Management of Atonic Postpartum Hemorrhage","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2019-04-01","conditions":"Postpartum Hemorrhage","enrollment":135},{"nctId":"NCT02277041","phase":"PHASE4","title":"Carbetocin Versus Misoprostol in Cases With Placenta Previa After C.S.","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2014-10","conditions":"Postpartum Hemorrhage","enrollment":200},{"nctId":"NCT02277067","phase":"PHASE4","title":"Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S.","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2014-10","conditions":"Postpartum Hemorrhage","enrollment":200},{"nctId":"NCT04595812","phase":"PHASE4","title":"Methods to Reduce Blood Loss in Abdominal Myomectomy","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-11-01","conditions":"Abdominal Myomectomy, Blood Loss","enrollment":120},{"nctId":"NCT03708497","phase":"NA","title":"Carbetocin Versus Oral Tranexamic Acid Plus, Buccal Misoprostol on Blood Loss After Vaginal Delivery","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2018-12-01","conditions":"Postpartum Hemorrhage","enrollment":360},{"nctId":"NCT03710317","phase":"NA","title":"Carbetocin Versus Buccal Misoprostol Plus IV Tranexamic Acid for Prevention of Postpartum Hemorrhage at Cesarean Section","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2018-12-01","conditions":"Cesarean Section Complications","enrollment":400},{"nctId":"NCT04313218","phase":"","title":"Carbetocin Versus Misoprostol. A Retrospective Comparative Study","status":"COMPLETED","sponsor":"Port Said University hospital","startDate":"2018-01-01","conditions":"Cesarean Section Complications","enrollment":300},{"nctId":"NCT04300452","phase":"PHASE4","title":"Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage","status":"UNKNOWN","sponsor":"National and Kapodistrian University of Athens","startDate":"2018-04-05","conditions":"Postpartum Hemorrhage","enrollment":100},{"nctId":"NCT03777878","phase":"NA","title":"Carbetocin Versus Oxytocin Infusion Plus Tranexamic Acid During Cesarean Section","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2019-01-01","conditions":"Cesarean Section Complications","enrollment":400},{"nctId":"NCT02642263","phase":"PHASE4","title":"Effect of the Uterotonic Carbetocin on Acute Post Cesarean-Section Pain","status":"UNKNOWN","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2019-02-01","conditions":"Cesarean Delivery","enrollment":78},{"nctId":"NCT02221531","phase":"PHASE4","title":"Carbetocin Trial: Carbetocin Appropriate Rate Better Equilibrium Between Tonus (TOnus) and CIrculatioN","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2014-08","conditions":"Complications; Cesarean Section, Anesthesia; Reaction","enrollment":140},{"nctId":"NCT02636816","phase":"PHASE4","title":"Cardiovascular Effects of Carbetocin Given During Elective Cesarean","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2016-03","conditions":"Effect of Carbetocin on Cardiovascular System, Pregnancy","enrollment":57},{"nctId":"NCT02101567","phase":"PHASE4","title":"Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Haemorrhage Following Caesarean Section","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2014-05","conditions":"Bleeding, Anemia","enrollment":200},{"nctId":"NCT02079558","phase":"PHASE2","title":"Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section","status":"COMPLETED","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2012-09","conditions":"Postpartum Hemorrhage","enrollment":220},{"nctId":"NCT01827124","phase":"PHASE4","title":"Randomized Clinical Trial for Comparison Of Intravenous Carbeitocin Versus Oxytocin In Management Of Placental Delivery In Second Trimester Interruption","status":"UNKNOWN","sponsor":"Wafaa Uthman Ahmed","startDate":"2013-04","conditions":"CARBETOCIN FOR PREVENTION OF PLACENTAL RETAINED","enrollment":140}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Duratocin"],"phase":"marketed","status":"active","brandName":"Carbetocin infusion","genericName":"Carbetocin infusion","companyName":"Ciusss de L'Est de l'Île de Montréal","companyId":"ciusss-de-l-est-de-l-le-de-montr-al","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Carbetocin is a synthetic oxytocin analogue that binds to oxytocin receptors to stimulate uterine contractions and promote milk letdown. Used for Prevention and treatment of postpartum hemorrhage, Promotion of milk letdown in lactation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}